老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neoleukin Therapeutics, Inc.

3.49
0.0000
成交量：- -
成交额：39.34万
市值：3,279.87万
市盈率：-1.14
高：3.49
开：3.49
低：3.49
收：3.49
52周最高：4.70
52周最低：1.90
股本：939.79万
流通股本：544.90万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-3.0649
每股收益(LYR):-5.2115
净资产收益率：-37.88%
总资产收益率：-18.70%
市净率：0.44
市盈率(LYR):-0.67

数据加载中...

总览公司新闻资讯公告
2020/03/20

重要事件披露

Current report, items 4.01 and 9.01
2020/03/12

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

重要事件披露

Current report, items 5.08 and 8.01
2020/02/25

重要事件披露

Current report, item 5.02
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2019/12/30

重要事件披露

Current report, item 1.01
2019/12/27

超过5%披露

General statement of acquisition of beneficial ownership
2019/12/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/20

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/19

重要事件披露

Current report, items 1.01, 3.02, 8.01, and 9.01
2019/12/17

重要事件披露

[Amend] Current report, item 9.01
2019/12/05

重要事件披露

Current report, items 7.01 and 9.01
2019/11/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/15

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/14

重要事件披露

Current report, items 5.07, 8.01, and 9.01
更多